Study of Computer Attention Training Programs in Schools for Children With Attention Deficit/Hyperactivity Disorder
NCT ID: NCT01583829
Last Updated: 2017-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
104 participants
INTERVENTIONAL
2009-05-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Trial of Computer-based Attention-training Systems in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00956605
Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD
NCT02358941
A Biofeedback Training in Schoolchildren With an Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT02572180
NEUROFEEDBACK on Event-Related Potential (ERP)
NCT03289793
Efficacy of Neuro+ Attention Training
NCT02642055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
104 children with ADHD in grades 2 and 4 are randomly assigned to receive the NF, CT, or a Waitlist-Control (WLC) condition that receives NF or CT the following academic year. Children receive forty 45-minute sessions three times a week at school for 4 months. A comprehensive assessment, consists of data completed by teachers, parents, participants, and double-blind classroom observations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurofeedback
Neurofeedback
3 times per week for 45 minutes for a total of 40 sessions
Cognitive Training
Cognitive Training
3 times per week for 45 minutes for a total of 40 sessions
Waitlist Control
Waitlist Control
6 30 minute calm breathing sessions over the course of 4 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback
3 times per week for 45 minutes for a total of 40 sessions
Cognitive Training
3 times per week for 45 minutes for a total of 40 sessions
Waitlist Control
6 30 minute calm breathing sessions over the course of 4 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* combined IQ (Intelligence Quotient) at or above 80,
* ability to read English sufficiently to complete assessments and intervention protocols
Exclusion Criteria
* coexisting diagnosis of conduct disorder,
* pervasive developmental disorder, or
* other serious mental illness (eg., bipolar disorder, psychosis, autism)
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Naomi J Steiner, MD
Role: PRINCIPAL_INVESTIGATOR
Tufts Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts Medical Center
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8926
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.